• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中介遗传性视网膜疾病对生活质量的影响评估和基因治疗的潜在获益。

Estimation of impact of mediated inherited retinal disease on quality of life and the potential benefits of gene therapy.

机构信息

Acaster Lloyd Consulting, London, UK

Acaster Lloyd Consulting, London, UK.

出版信息

Br J Ophthalmol. 2019 Nov;103(11):1610-1614. doi: 10.1136/bjophthalmol-2018-313089. Epub 2019 Jan 18.

DOI:10.1136/bjophthalmol-2018-313089
PMID:30658988
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6855782/
Abstract

BACKGROUND/AIMS: In rare diseases, health-related quality of life (HRQL) data can be difficult to capture. Given the ultrarare nature of -mediated inherited retinal disease (IRD), it was not feasible to recruit a patient sample and collect HRQL data prospectively. The objectives of this study were to develop health state descriptions of -mediated IRD, and to estimate associated patient utilities.

METHODS

Vignette descriptions of IRD states were developed and then assessed to elicit utilities. The vignettes ranged from moderate vision loss through to hand motion to no light perception (NLP). Six retina specialists with additional expertise in IRDs provided a proxy valuation of the vignettes using generic measures of health-the 5-level version of EQ-5D-5L and Health Utility Index 3 (HUI3). The data were then scored using standard methods for each instrument.

RESULTS

Weights from both HRQL measures revealed a large decline in scores with vision loss. The EQ-5D-5L weights ranged from 0.709 for moderate vision loss to 0.152 for hand motion to NLP. The HUI3 weights ranged from 0.519 to - 0.039, respectively. A decline was seen on both measures, and the degree of decline from moderate vision loss to NLP was identical on both (-0.56).

CONCLUSION

This is the first study to report HRQL weights (or utilities) for health states describing different levels of vision loss in patients with IRD, specifically those with -mediated disease. The parallel decline in scores from the EQ-5D and HUI3 corroborates the substantial impact of progressive vision loss on HRQL.

摘要

背景/目的:在罕见病中,健康相关生活质量(HRQL)数据可能难以获取。鉴于 - 介导的遗传性视网膜疾病(IRD)的超罕见性质,招募患者样本并前瞻性地收集 HRQL 数据是不可行的。本研究的目的是制定 - 介导的 IRD 的健康状况描述,并估计相关的患者效用。

方法

开发了 IRD 状态的情景描述,然后对其进行评估以引出效用。这些情景从中度视力丧失到手动视力到无光感(NLP)不等。六名具有 IRD 额外专业知识的视网膜专家使用通用健康衡量标准 - EQ-5D-5L 的 5 级版本和健康效用指数 3(HUI3)对情景进行了代理评估。然后使用每种仪器的标准方法对数据进行评分。

结果

两种 HRQL 衡量标准的权重都显示出随着视力丧失而导致的分数大幅下降。EQ-5D-5L 的权重从中度视力丧失的 0.709 到手动视力的 0.152 到 NLP 的 0.152。HUI3 的权重分别为 0.519 至 -0.039。两种衡量标准都出现了下降,从中度视力丧失到 NLP 的下降程度在两种衡量标准上完全相同(-0.56)。

结论

这是第一项报告描述 IRD 患者不同程度视力丧失的健康状况的 HRQL 权重(或效用)的研究,特别是那些与 - 介导疾病相关的患者。EQ-5D 和 HUI3 的评分平行下降证实了进行性视力丧失对 HRQL 的重大影响。

相似文献

1
Estimation of impact of mediated inherited retinal disease on quality of life and the potential benefits of gene therapy.中介遗传性视网膜疾病对生活质量的影响评估和基因治疗的潜在获益。
Br J Ophthalmol. 2019 Nov;103(11):1610-1614. doi: 10.1136/bjophthalmol-2018-313089. Epub 2019 Jan 18.
2
EQ-5D-5L health utility scores in Australian adults with inherited retinal diseases: A cross-sectional survey.澳大利亚遗传性视网膜疾病患者的 EQ-5D-5L 健康效用评分:一项横断面调查。
Acta Ophthalmol. 2024 Aug;102(5):e736-e745. doi: 10.1111/aos.16634. Epub 2024 Jan 16.
3
Cost Utility of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease.双等位基因 RPE65 介导的遗传性视网膜疾病患者接受 voretigene neparvovec 的成本效用分析。
Value Health. 2019 Feb;22(2):161-167. doi: 10.1016/j.jval.2018.09.2841. Epub 2018 Oct 25.
4
Voretigene neparvovec-rzyl for treatment of -mediated inherited retinal diseases: a model for ocular gene therapy development.Voretigene neparvovec-rzyl 治疗 - 介导的遗传性视网膜疾病:眼部基因治疗开发的模型。
Expert Opin Biol Ther. 2020 Jun;20(6):565-578. doi: 10.1080/14712598.2020.1740676. Epub 2020 Mar 25.
5
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis.类风湿关节炎中通用间接效用测量方法(健康效用指数2、健康效用指数3、SF-6D和欧洲五维度健康量表)与疾病特异性工具(类风湿关节炎生活质量量表和健康评估问卷)的比较。
Soc Sci Med. 2005 Apr;60(7):1571-82. doi: 10.1016/j.socscimed.2004.08.034.
6
EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.EQ-5D-5L 比 EQ-5D-3L 更能反映白内障手术治疗获益。
Patient. 2019 Aug;12(4):383-392. doi: 10.1007/s40271-018-00354-7.
7
Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.测量方法的选择:听力有问题者中EQ-5D、HUI2和HUI3的比较
Qual Life Res. 2007 Oct;16(8):1439-49. doi: 10.1007/s11136-007-9237-x. Epub 2007 Jul 24.
8
Shared decision-making, control preferences and psychological well-being in patients with RPE65 deficiency awaiting experimental gene therapy.等待实验性基因治疗的RPE65缺乏症患者的共同决策、控制偏好与心理健康
Ophthalmic Res. 2015;54(2):96-102. doi: 10.1159/000435887. Epub 2015 Aug 8.
9
Interpreting parental proxy reports of (health-related) quality of life for children with unilateral cochlear implants.解读单侧人工耳蜗植入儿童家长代理报告的(与健康相关的)生活质量
Int J Pediatr Otorhinolaryngol. 2007 Mar;71(3):435-45. doi: 10.1016/j.ijporl.2006.11.011. Epub 2006 Dec 11.
10
A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.一种用于获取健康状态偏好的混合建模方法:葡萄牙 EQ-5D-5L 值集。
Qual Life Res. 2019 Dec;28(12):3163-3175. doi: 10.1007/s11136-019-02226-5. Epub 2019 Jun 14.

引用本文的文献

1
The Impact of Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) on Health-Related Quality of Life (HRQoL): Elicitation of Health State Utility Values Through Time Trade-Off (TTO) and EQ-5D.活化磷脂酰肌醇3-激酶δ综合征(APDS)对健康相关生活质量(HRQoL)的影响:通过时间权衡法(TTO)和EQ-5D得出健康状态效用值
Adv Ther. 2025 Jun 21. doi: 10.1007/s12325-025-03252-1.
2
"My child can't see"-workup and management of children with low vision: a joint workshop of the AAPOS Low Vision Rehabilitation and Genetic Eye Diseases Committees.“我的孩子看不见了”——儿童视力低下的检查与管理:美国小儿眼科与斜视学会低视力康复委员会和遗传性眼病委员会联合研讨会
J AAPOS. 2025 Jun;29(3):104229. doi: 10.1016/j.jaapos.2025.104229. Epub 2025 May 27.
3

本文引用的文献

1
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.治疗 RPE65 介导的遗传性视网膜营养不良患者的 voretigene neparvovec(AAV2-hRPE65v2)的疗效和安全性:一项随机、对照、开放标签、3 期临床试验。
Lancet. 2017 Aug 26;390(10097):849-860. doi: 10.1016/S0140-6736(17)31868-8. Epub 2017 Jul 14.
2
Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions.莱伯先天性黑蒙/早发性严重视网膜营养不良:临床特征、分子遗传学及治疗干预措施
Br J Ophthalmol. 2017 Sep;101(9):1147-1154. doi: 10.1136/bjophthalmol-2016-309975. Epub 2017 Jul 8.
3
Patient-Reported Social Impact of Molecularly Confirmed Retinitis Pigmentosa.
患者报告的分子确诊视网膜色素变性的社会影响。
J Clin Med. 2025 May 6;14(9):3229. doi: 10.3390/jcm14093229.
4
Leber hereditary optic neuropathy: utilities and carer burden from British and Irish participants.Leber遗传性视神经病变:来自英国和爱尔兰参与者的效用及照料者负担
Orphanet J Rare Dis. 2025 May 7;20(1):219. doi: 10.1186/s13023-025-03737-w.
5
People and Families Affected by Glycogen Storage Disease Type Ia: An Analysis of Narrative Accounts Written by Individuals Living with GSDIa and Their Caregivers.受Ia型糖原贮积病影响的个人和家庭:对Ia型糖原贮积病患者及其照顾者所撰写的叙述性记录的分析。
J Health Econ Outcomes Res. 2025 Apr 3;12(1):120-128. doi: 10.36469/001c.131811. eCollection 2025.
6
Health state utilities associated with X-linked retinitis pigmentosa (XLRP).与X连锁视网膜色素变性(XLRP)相关的健康状态效用值。
Eur J Health Econ. 2025 Mar 17. doi: 10.1007/s10198-025-01761-y.
7
A standard gamble study to determine health state utilities associated with seizures in glioma in the UK.一项在英国开展的标准博弈研究,旨在确定与胶质瘤癫痫发作相关的健康状态效用值。
Health Qual Life Outcomes. 2025 Mar 11;23(1):22. doi: 10.1186/s12955-025-02348-0.
8
Consecutive Affinity and Ion-Exchange Chromatography for AAV9 Vectors Purification.用于AAV9载体纯化的连续亲和与离子交换色谱法
Biomedicines. 2025 Feb 5;13(2):361. doi: 10.3390/biomedicines13020361.
9
The value of genetic testing in pediatric and adult ophthalmology.基因检测在儿科和成人眼科中的价值。
Med Genet. 2025 Feb 12;37(1):11-18. doi: 10.1515/medgen-2024-2059. eCollection 2025 Apr.
10
Insights in AAV-mediated antigen-specific immunity and a strategy for AAV vaccine dose reduction through AAV-extracellular vesicle association.腺相关病毒介导的抗原特异性免疫的见解以及通过腺相关病毒与细胞外囊泡结合来降低腺相关病毒疫苗剂量的策略。
Mol Ther Methods Clin Dev. 2024 Oct 18;32(4):101358. doi: 10.1016/j.omtm.2024.101358. eCollection 2024 Dec 12.
Leber's congenital amaurosis and the role of gene therapy in congenital retinal disorders.
莱伯先天性黑蒙以及基因治疗在先天性视网膜疾病中的作用。
Int J Ophthalmol. 2017 Mar 18;10(3):480-484. doi: 10.18240/ijo.2017.03.24. eCollection 2017.
4
Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report.临床研究中经济模型的健康状态效用评估:一份药物经济学与结果研究协会良好研究实践特别工作组报告
Value Health. 2016 Sep-Oct;19(6):704-719. doi: 10.1016/j.jval.2016.06.001.
5
Comprehensive genotyping reveals RPE65 as the most frequently mutated gene in Leber congenital amaurosis in Denmark.全面基因分型显示,RPE65是丹麦莱伯先天性黑蒙中最常发生突变的基因。
Eur J Hum Genet. 2016 Jul;24(7):1071-9. doi: 10.1038/ejhg.2015.241. Epub 2015 Dec 2.
6
How to measure distance visual acuity.如何测量远视力。
Community Eye Health. 2014;27(85):16.
7
Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.使用通用和特定疾病健康相关生活质量测量指标进行 NICE 决策制定:系统评价、统计建模和调查。
Health Technol Assess. 2014 Feb;18(9):1-224. doi: 10.3310/hta18090.
8
Next generation sequencing-based molecular diagnosis of retinitis pigmentosa: identification of a novel genotype-phenotype correlation and clinical refinements.基于下一代测序的视网膜色素变性分子诊断:新型基因型-表型相关性的鉴定和临床改进。
Hum Genet. 2014 Mar;133(3):331-45. doi: 10.1007/s00439-013-1381-5. Epub 2013 Oct 24.
9
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets.EQ-5D-5L 的临时评分:将 EQ-5D-5L 映射到 EQ-5D-3L 值集。
Value Health. 2012 Jul-Aug;15(5):708-15. doi: 10.1016/j.jval.2012.02.008. Epub 2012 May 24.
10
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).新的 EQ-5D 五维版本(EQ-5D-5L)的制定和初步测试。
Qual Life Res. 2011 Dec;20(10):1727-36. doi: 10.1007/s11136-011-9903-x. Epub 2011 Apr 9.